Bentley is a specialty pharmaceutical company with two distinct businesses. Its emerging drug delivery business is focused on commercializing the Company’s patented technology with primary concentration in the U.S. Its established generic pharmaceutical manufacturing and distribution business is focused in the European Union.
BENTLEY PHARMACEUTICALS ANNOUNCES FIRST QUARTER FINANCIAL RESULTS
Reports Revenues of $40.0 Million in the First Quarter; Revenues Increase 27% over 2007 First Quarter
BENTLEY PHARMACEUTICALS TO RELEASE FIRST-QUARTER 2008 FINANCIAL RESULTS ON MAY 8, 2008
TEVA TO ACQUIRE BENTLEY PHARMACEUTICALS
Acquisition Will Provide Teva with a Strong Platform to Become a Leading Player in Spain